Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 EUR | +6.84% | +8.70% | +17.92% |
Jun. 05 | Immutep Completes Stock Offering | MT |
Jun. 03 | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
Sales 2024 * | 3.55M 2.35M 2.19M | Sales 2025 * | 4.45M 2.95M 2.75M | Capitalization | 584M 386M 361M |
---|---|---|---|---|---|
Net income 2024 * | -46M -30.42M -28.42M | Net income 2025 * | -54M -35.72M -33.36M | EV / Sales 2024 * | 127 x |
Net cash position 2024 * | 135M 89.14M 83.26M | Net cash position 2025 * | 92.39M 61.11M 57.08M | EV / Sales 2025 * | 110 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-10.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
1 day | +6.84% | ||
1 week | +8.70% | ||
Current month | -2.34% | ||
1 month | -7.41% | ||
3 months | +11.61% | ||
6 months | +35.87% | ||
Current year | +17.92% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 51 | 10-12-31 |
David Fang
DFI | Director of Finance/CFO | - | 18-02-28 |
Florian Vogl
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Howard
CHM | Chairman | 74 | 13-05-07 |
Marc Voigt
CEO | Chief Executive Officer | 51 | 10-12-31 |
Anne Anderson
BRD | Director/Board Member | - | Feb. 13 |
Date | Price | Change |
---|---|---|
24-06-14 | 2.5 | +6.84% |
24-06-13 | 2.34 | -3.31% |
24-06-12 | 2.42 | 0.00% |
24-06-11 | 2.42 | -1.63% |
24-06-10 | 2.46 | -2.38% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 02:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- IMM Stock
- YP1A Stock